Pinnacle Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,880
| Closed | -$297K | – | 837 |
|
|
2023
Q3 | $297K | Sell |
2,880
-105
| -4% | -$10.8K | 0.01% | 677 |
|
|
2023
Q2 | $363K | Buy |
2,985
+346
| +13% | +$42K | 0.01% | 633 |
|
|
2023
Q1 | $405K | Sell |
2,639
-111
| -4% | -$17K | 0.01% | 562 |
|
|
2022
Q4 | $494K | Sell |
2,750
-307
| -10% | -$55.1K | 0.01% | 503 |
|
|
2022
Q3 | $361K | Buy |
3,057
+552
| +22% | +$65.2K | 0.01% | 561 |
|
|
2022
Q2 | $358K | Sell |
2,505
-258
| -9% | -$36.9K | 0.01% | 573 |
|
|
2022
Q1 | $476K | Buy |
2,763
+230
| +9% | +$39.6K | 0.01% | 574 |
|
|
2021
Q4 | $643K | Buy |
2,533
+682
| +37% | +$173K | 0.01% | 518 |
|
|
2021
Q3 | $712K | Buy |
1,851
+120
| +7% | +$46.2K | 0.01% | 501 |
|
|
2021
Q2 | $407K | Buy |
+1,731
| New | +$407K | 0.01% | 585 |
|